Vanguard Group
BNTC icon

Vanguard Group’s Benitec Biopharma BNTC Stock Holding History

Vanguard Group’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$15.8M Buy
1,174,758
+182,644
+18% +$2.53M ﹤0.01% 2732
2025
Q3 		$13.9M Buy
992,114
+22,948
+2% +$293K ﹤0.01% 2800
2025
Q2 		$11.3M Buy
969,166
+642,132
+196% +$8.98M ﹤0.01% 2834
2025
Q1 		$4.25M Buy
327,034
+27,013
+9% +$327K ﹤0.01% 3236
2024
Q4 		$3.79M Buy
300,021
+86,954
+41% +$939K ﹤0.01% 3373
2024
Q3 		$1.96M Sell
213,067
-2,003
-0.9% -$17.9K ﹤0.01% 3564
2024
Q2 		$1.5M Buy
215,070
+198,369
+1,188% +$1.46M ﹤0.01% 3655
2024
Q1 		$87.7K Hold
16,701
– – ﹤0.01% 4255
2023
Q4 		$53.9K Buy
+16,701
New +$55.7K ﹤0.01% 4364
2023
Q3 		– Sell
-4,398
Closed -$17.8K – 4546
2023
Q2 		$17.8K Hold
4,398
– – ﹤0.01% 4523
2023
Q1 		$15.7K Hold
4,398
– – ﹤0.01% 4536
2022
Q4 		$12.7K Hold
4,398
– – ﹤0.01% 4504
2022
Q3 		$28K Sell
4,398
-212
-5% -$2.69K ﹤0.01% 4577
2022
Q2 		$91K Hold
4,610
– – ﹤0.01% 4557
2022
Q1 		$183K Hold
4,610
– – ﹤0.01% 4546
2021
Q4 		$205K Hold
4,610
– – ﹤0.01% 4557
2021
Q3 		$280K Buy
4,610
+212
+5% +$13.9K ﹤0.01% 4456
2021
Q2 		$318K Buy
4,398
+1,328
+43% +$104K ﹤0.01% 4324
2021
Q1 		$270K Buy
+3,070
New +$209K ﹤0.01% 4226

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group's BNTC Position: Q4 2025 in Review

Vanguard Group increased its Benitec Biopharma (BNTC) stake by 18% in Q4 2025, buying an estimated $2.53M and bringing the position to 1,174,758 shares worth $15.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

Vanguard Group first reported a position in BNTC in Q1 2021 and has held it in 19 quarters since. 72 funds tracked by Wall St. Rank hold BNTC as of Q4 2025.

  • Vanguard Group held 1,174,758 shares of Benitec Biopharma worth $15.8M as of Q4 2025.
  • Vanguard Group bought 182,644 Benitec Biopharma shares in Q4 2025, an estimated $2.53M.
  • Benitec Biopharma made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2732 holding.
  • Vanguard Group first reported a position in Benitec Biopharma in Q1 2021 and has held it in 19 quarters since.
  • 72 funds tracked by Wall St. Rank held Benitec Biopharma as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.